Merck
MRK
$0.90 (0.93%)
1D
1W
3M
1Y
5Y
ALL
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 2 days ago • MRK
Merck Announces First-Quarter 2025 DividendSeeking Alpha • 2 days ago • MRK
Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)Barrons • 2 days ago • MRK
Merck's Cancer Shot Works. Its Post-Keytruda Plans Are Shaping Up Again.CNBC Television • 2 days ago • MRK
Injectable version of cancer drug Keytruda works as well as current IV form: MerckMarket Watch • 2 days ago • MRK
Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulationCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.